13 startup projects qualify for the first phase of BaseLaunch
The BaseLaunch Healthcare Accelerator program from BaselArea.swiss started on September 14. Over 100 applications were received from more than 30 countries, and the selection committee…
clement18.09.2017
BaseLaunch Accelerator gains another healthcare partner
BaseLaunch Accelerator gains another healthcare partner Pharma and diagnostics company Roche has joined Johnson & Johnson Innovation, Novartis Venture Fund and Pfizer to become the…
clement08.09.2017
Aurealis Pharma AG raises 5.6 million Swiss francs
Aurealis Pharma AG has closed a 5.6 million Swiss franc financing round. Headquartered in Basel and Finland, the biotechnology company develops medications for cancer and…
clement28.08.2017
Cellestia compound enters into clinical development
The Basel-based biotechnology company Cellestia has received approval for the first clinical trial on its compound CB-103. The clinical trial will be open to patients…
clement15.08.2017
